Stock Price Quote

BIOFIL CHEMICALS & PHARMACEUTICALS LTD.

NSE : BIOFILCHEMBSE : 524396ISIN CODE : INE829A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE67.88-0.52 (-0.76 %)
PREV CLOSE ( ) 68.40
OPEN PRICE ( ) 67.03
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2315
TODAY'S LOW / HIGH ( )66.09 68.80
52 WK LOW / HIGH ( )41.01 78.8
NSE67.60-1.05 (-1.53 %)
PREV CLOSE( ) 68.65
OPEN PRICE ( ) 67.00
BID PRICE (QTY) 67.60 (1177)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 56102
TODAY'S LOW / HIGH( ) 65.65 68.65
52 WK LOW / HIGH ( )41.3 79
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1985
Management Info
Ramesh Shah - Chairman Ramesh Shah - Managing Director
Registered Office

Address 11/12,Sector E, Sanwer Road,Industrial Area,
Indore,
Madhya Pradesh-452015

Phone 0731-2723016

Email bcplcompliance@gmail.com

Website www.biofilgroup.net

Registrars Details
Ankit Consultancy Pvt Ltd
Plot No 60,Electronic Complex,Pardeshipura,Indore
Listing : BSE, NSE

NEWS

03Apr Biofil Chemicals & Pharmaceuticals inf
Biofil Chemicals & Pharmaceuticals has informed that it attached Cer..
12Mar Biofil Chemicals & Pharmaceuticals inf
Biofil Chemicals & Pharmaceuticals has informed that the Exchange ha..
23Feb Notice of Postal Ballot
Inter alia, to consider and approve :- 1. Reconstitution of Audit Comm..
06Feb Notice of Postal Ballot
Inter alia, approved:- 1. Reconstitution of Audit Committee, Nominati..
01Nov Biofil Chemicals & Pharmaceuticals sub
Biofil Chemicals & Pharmaceuticals has informed that the meeting of..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit0.9300000000000035.60999999999998
Gross Profit 1.13 7.93999999999998
Operating Profit 2.212.65
Net Sales 50.32300.35

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE)
peergroup  1455.20 (10.00%)
M.Cap ( in Cr)846.88
Solara Active Pharma (BSE)
peergroup  551.45 (16.32%)
M.Cap ( in Cr)1985.01
Abbott India (BSE)
peergroup  26131.85 (0.29%)
M.Cap ( in Cr)55528.36
Windlas Biotech (BSE)
peergroup  555.05 (6.97%)
M.Cap ( in Cr)1154.42
Concord Biotech (BSE)
peergroup  1595.25 (1.05%)
M.Cap ( in Cr)16688.90

Shareholding Pattern

NON-INSTITUTION 53.08%
PROMOTERS 46.82%
FI/BANKS/INSURANCE 0.08%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Biofil Chemicals & Pharmaceuticals Ltd.

Biofil Chemicals & Pharmaceuticals Ltd. was incorporated in the year 1985. Its today's share price is 67.88. Its current market capitalisation stands at Rs 110.47 Cr. In the latest quarter, company has reported Gross Sales of Rs. 300.35 Cr and Total Income of Rs.301.32 Cr. The company's management includes Gayatri Padiyar, Shweta Verma, Satish Beohar, Ashok Kumar Ramawat, Ketan Shah, Romil Shah, Ramesh Shah, Ramesh Shah.

It is listed on the BSE with a BSE Code of 524396 , NSE with an NSE Symbol of BIOFILCHEM and ISIN of INE829A01014. It's Registered office is at 11/12,Sector E, Sanwer Road,Industrial AreaIndore-452015, Madhya Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Maheshwari & Gupta, SN Gadiya & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.